Toronto, Ontario and New York, New York--(Newsfile Corp. - October 19, 2026) - DelphX Capital Markets Inc. (TSXV: DELX) (OTC Pink: DPXCF) ("DelphX" or the "Company"), a leader in the development of new classes of structured products, announces that it has commenced a non-brokered private placement of up to 7,000,000 units of the Company (the "Units") at a subscription price of C$0.01 per Unit, for gross proceeds of up to approximately C$70,000 (the "Offering").
Each Unit consists of one common share of the Company (a "Common Share") and one Common Share purchase warrant (a "Warrant"). Each Warrant entitles the holder to purchase one additional Common Share at an exercise price of C$0.06 for a period of two years from the date of issuance.
The Company expects to close the Offering on or before October 26, 2026.
In connection with the Offering, DelphX may elect to pay finder's fees to eligible finders in accordance with the policies of the TSX Venture Exchange. Details of any finder's fees paid will be announced at a later date.
DelphX intends to use the net proceeds of the Offering for working capital and corporate overhead. No more than 10% of the gross proceeds of the Offering will be used to fund investor relations activities.
Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance and, as the Units are priced at less than C$0.05 per Unit, will be subject to the Exchange Hold Period and legended accordingly.
OTC Markets Quotation
DelphX's common shares are quoted in the United States on OTC Markets under the symbol "DPXCF," and that quotation has moved to the Pink Limited market. The Company does not intend to maintain its OTC quotation, and the DPXCF quote may end in the coming months. The OTC quotation is a secondary US quote only. The Company's primary listing on the TSX Venture Exchange under the symbol "DELX" is unaffected.
Holders of DPXCF shares own the same common shares that trade on the TSX Venture Exchange. Their shareholdings do not change. Shareholders who hold their shares through a US brokerage account should contact their broker about transferring their position to an account that can trade on the TSX Venture Exchange. Registered shareholders can contact the Company's transfer agent, Odyssey Trust Company, at 1-888-290-1175 (toll-free, Canada and US), 1-587-885-0960 (direct), or shareholders@odysseytrust.com.
About DelphX Capital Markets Inc.
DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:
Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;
Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.
All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.
For more information about DelphX, please visit www.delphx.com.
For further information, please contact:
George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160
Forward-Looking Statements
This news release contains "forward-looking information" within the meaning of applicable Canadian securities laws, including statements regarding the proposed non-brokered private placement, the anticipated gross proceeds, the expected closing date, the intended use of proceeds, the Company's intention not to maintain its OTC quotation and the timing of any end to the DPXCF quotation. Forward-looking information is based on the Company's current expectations and assumptions and is subject to risks and uncertainties that could cause actual results to differ materially, including the risk that the Offering is not completed on the terms contemplated, by the expected date or at all, that the Offering is not fully subscribed, that regulatory approval from the TSX Venture Exchange is not obtained, and that the timing or manner in which the DPXCF quotation ends differs from what the Company expects. Readers are cautioned not to place undue reliance on forward-looking information, which speaks only as of the date of this release. The Company undertakes no obligation to update such information except as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/319297
